Table 1.
Clinical data study for the impact of SARS-CoV-2 on comorbidities.
|
Patients (No.) |
Age (years) |
Comorbidities % |
References |
||||
|---|---|---|---|---|---|---|---|
| All | Male | HT | DM | RD | CVD | ||
| 41 | 30 | 49.0 | 15.0 | 20.0 | 2.0 | 15.0 | (Yang et al., 2020) |
| 137 | 61 | 57.0 | 9.5 | 10.2 | 1.5 | 7.3 | (K. Liu et al., 2020) |
| 12 | 8 | 53.7 | 25.0 | 16.7 | 8.3 | 33.3 | (Y. Liu et al., 2020) |
| 138 | 75 | 56.0 | 31.2 | 10.1 | 2.9 | 14.5 | (Bai et al., 2020) |
| 140 | 71 | 57.0 | 30.0 | 12.1 | 1.4 | 5.0 | (J. jin Zhang et al., 2020) |
| 9 | 5 | 35.2 | 0 | 11.1 | 0 | 0 | (MQ et al., 2020) |
| 1099 | 640 | 47.0 | 14.9 | 7.4 | 1.4 | 2.5 | (Guan et al., 2020) |